You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
North American Chromatography Solvents (Chromatography Reagents) The North American chromatography solvents market has gained a significant share in the total analytical chromatography reagnets market.The market was pegged at $687.9 million in 2012 and is estimated to achieve $1152.3 million by 2018, with a growing CAGR of 9.2%. This market can be segmented on the basis of products and technology, and major applications. The report further segements the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market is also have been considered in this report. |
Upcoming |
|
|
North American Claim Management System The North American payer claim management market has gained a significant share in the total payer claim management market. The market was pegged at $1811 million in 2012 and is estimated to achieve $2576 million by 2018, with a growing CAGR of 6.2%. The market can be segmented on the basis of types and various types of deployments and componenets, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
European Chromatography Solvents (Chromatography Reagents) The European chromatography solvents market accoutns for a major share in the global chromatography solvents market. The market was valued at $492.7 million in 2012 and is expected to reach $806.6 million by 2018, at a CAGR of 8.9% from 2013 to 2018. The report provides details of the market value forecasts, segmentation, market metrics, and the opportunities in the market for existing as well as new players. A deep-dive analysis of the top players of this market have been elaborated in this report, along with the competitive landscape of the market. |
Upcoming |
|
|
Europe Polymerase Chain Reaction (PCR) The European polymerase chain reaction market has gained a significant share in the total Polymerase chain reaction market. The market was pegged at $1154 million in 2012 and is estimated to achieve $2708 million by 2018, with a growing CAGR of 16.2%. These reagents can be segmented on the basis of products and various types of preparative reagents, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report. |
Upcoming |
|
|
Asian Polymerase Chain Reaction (PCR) The Asian polymerase chain reaction market has gained a significant share in the total Polymerase chain reaction market. The market was pegged at $1046 million in 2012 and is estimated to achieve $2915 million by 2018, with a growing CAGR of 20.3%. These reagents can be segmented on the basis of products and various types of preparative reagents, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report.” |
Upcoming |
|
|
North America Polymerase Chain Reaction (PCR) The North American polymerase chain reaction market was valued at $1,456 million in 2012 and is estimated to reach $2,724 million by 2018, at a CAGR of 11.3% from 2013 to 2018. The market report provides insights into the market value forecasts, market dynamics such as drivers & restraints, competitive scenario of the market, and the opportunities in the market.In addition, a deep-dive analysis of the top market players has been provided in this report. |
Upcoming |
|
|
North American DNA Microarray The North American geographic segment of the global DNA Microarray market was valued at $423.2 million in 2013 and is the largest regional contributor to the global genomics market. The North American region is expected to witness a relatively large number of innovations in genomics research in terms of technology and expansion of application areas to improve human health. |
Upcoming |
|
|
Europe Closed MRI Systems It is segmented on basis of geographies. What makes our report unique? You can request 10% customization in the research matching your exact requirement for e.g. deep dive research in any specific geography or technology or... |
Upcoming |
|
|
Asia-Pacific DNA Microarray The Asn DNA microarray market has gained a significant share in the total DNA microarray market. The market was pegged at $274 million in 2012 and is estimated to achieve $791 million by 2018, with a growing CAGR of 21.5%. The market can be segmented on the basis of types and applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
North America In Situ Hybridization The North American hybridization market has gained a significant share in the total hybridization market. The market was pegged at $277 million in 2012 and is estimated to achieve $528 million by 2018, with a growing CAGR of 11.2%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Asia-Pacific In Situ Hybridization The Asian hybridization market has gained a significant share in the total hybridization market. The market was pegged at $200 million in 2012 and is estimated to achieve $403 million by 2018, with a growing CAGR of 12.4%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Ultrahigh Molecular weight Polyethylene(UHMWPE, UHMW) Ultra High Molecular Weight Polyethylene is a subset of thermoplastic polyethylene. It is odourless, nontoxic and highly resistant to corrosive chemicals. Its major end use segments are fiber, sheet, medical, manufacturing, and wire/cables. |
Upcoming |
|
|
Europe In Situ Hybridization The European hybridization market has gained a significant share in the total hybridization market. The market was pegged at $221 million in 2012 and is estimated to achieve $417 million by 2018, with a growing CAGR of 11%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
North America Isothermal Nucleic Acid Amplification The North American isothermal nucleic acid amplification market has gained a significant share in the isothermal nucleic acid amplification market. The market was pegged at $240 million in 2012 and is estimated to achieve $590 million by 2018, with a growing CAGR of 15.9%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Asian Isothermal Nucleic Acid Amplification The Asian isothermal nucleic acid amplification market has gained a significant share in the isothermal nucleic acid amplification market. The market was pegged at $173 million in 2012 and is estimated to achieve $450 million by 2018, with a growing CAGR of 17.1%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Isothermal Nucleic Acid Amplification Isothermal Nucleic Acid Amplification and DNA Sequencing, DNA... |
Upcoming |
|
|
Europe Isothermal Nucleic Acid Amplification The European isothermal nucleic acid amplification market has gained a significant share in the isothermal nucleic acid amplification market. The market was pegged at $192 million in 2012 and is estimated to achieve $466 million by 2018, with a growing CAGR of 15.7%. The market can be segmented on the basis of types and various types of applications, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
North America CDSS with EHR The North American CDSS-EHR market has gained a significant share in the total integrated CDSS market. The market was pegged at $51 million in 2012 and is estimated to achieve $85 million by 2018, with a growing CAGR of 8.7%. The market can be segmented on the basis of various types of components and deployment, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Europe CDSS with EHR The European CDSS-EHR market has gained a significant share in the total integrated CDSS market. The market was pegged at $9 million in 2012 and is estimated to achieve $14 million by 2018, with a growing CAGR of 7%. The market can be segmented on the basis of various types of components and deployment, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Asia CDSS with EHR The Asian CDSS-EHR market has gained a significant share in the total integrated CDSS market. The market was pegged at $5 million in 2012 and is estimated to achieve $8 million by 2018, with a growing CAGR of 5.9%. The market can be segmented on the basis of various types of components and deployment, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
Healthcare
